On Sep 23, Shah Sujal, Chief Executive Officer bought 3,100 shares of CymaBay Therapeutics Inc. (NASDAQ: CBAY), with the average selling price of the stock being $5.55 per share. The total amount realized from this purchase $17,205. A document was filed with the Securities and Exchange Commission to notify the public about the purchase of the shares.
In addition to that, Chief Executive Officer – Shah Sujal bought an extra 1,900 shares of this stock in a transaction that took place a day before, on Sep 20, with a share bought at an average of $5.50 and a total of $10,450 was realized from this transaction. After the transaction, the Chief Executive Officer – Shah Sujal was left with 111,900 shares of the company’s stock, which is currently worth around $615450.0.
The recent price movement of CBAY means that it is now down by -65.71% from its 52-week high and -0.41% down against its 52-week low prices. Over the past one week, the price volatility of CBAY stands at 5.90% while the volatility over the past one month is 5.56%. The beta score for this stock is 1.27. A beta score below 1 means that the stock has a low volatility while above 1 signifies that a stock is highly volatile at that particular moment, a data that traders use to keep tabs on their investments.
The company on 08/07/2019 published its latest quarterly earnings, with the report showing that the company recorded -0.31 earnings per share (EPS) during that period. This report was below the expectations of analysts of -0.29 by -0.02.
The shares of CymaBay Therapeutics Inc. (CBAY) dropped by -4.57%, leading to a loss of -$0.23 per share, and saw CBAY end the trading session at $4.80 on Tuesday 10/08/19. CBAY started the trading session at $4.99, before reaching a daily high of $5.06. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $4.755.
The trading volume on Tuesday stood at 1001510, which was below the stock’s 3-month average volume of 564.08K shares, out of a total 64.12M shares. As the price of the stock dipped, the market valuation of the company dropped to 324.91 million.
The shares of Pareteum Corporation (NASDAQ: TEUM) went down by -4.72% by the end of the recent trading session. This movement saw its price plunge to close at $1.21, which was lower than the previous closing price of $1.27. Over the past one week, the price of TEUM has slipped by -0.82%, while it has recorded a loss of -36.32% over the past one month. Its three-month performance saw TEUM lose -62.65% while its six-month performance saw it drop by -72.18%. The situation is different though over the past one year, as the stock price went down by -54.68%, while its year-to-date (YTD) price performance slipped by -28.40%. The stock price has gone up by +10.00% compared to its 90-day low, while it is down -68.32% compared to its 90-day high price.
Let’s take a look at its short, medium and long-term indicators. Composite Indicators shows that Trendspotter rated the stock as a Sell. In the short-term, the stock has a 20-day average volume of 4,991,315 shares, with the short-term indicators averagely rating the stock as a 100% Sell. A look at its medium-term indicators reveals that it has a 50-Day average volume of 4,064,388 shares and the indicators have an average rating of 100% Sell. The last indicators, the long-term see TEUM stock with a 100-Day average volume of 4,457,991 shares, giving it an average rating of 100% Sell. A look at the general picture of all short, medium and long-term indicators leaves TEUM with an average rating of 100% Sell.
Several brokerage firms sent out their reports TEUM stock not long ago. In its report sent out on April 26, 2019, Oppenheimer lowered its ratings on TEUM to a Outperform. In an earlier report on January 11, 2019, Maxim Group Initiated the stock to a Buy. Northland Capital meanwhile in its report on December 20, 2018 Initiated its rating of the stock to “Outperform”.
In related news to the company’s stock, around 44.90% shares are being held by institutional investors. In a recent SEC filing, the company revealed that 113 institutions currently hold the TEUM stock. In the last quarter, a 28,654,796 TEUM shares were in the possession of institutions. On the other hand, the company recorded 33 new institutions who bought it their stock, while 30 institutions sold their entire TEUM reserve. Of the current institutions investing in the stock, 58 increased their investment while 42 decreased their investment in the stock.